Go to
JCI Insight
Citations to this article
Sean T. H. Liu, … , Florian Krammer, Peter Palese
Published September 6, 2018
Citation Information: J Clin Invest. 2018;128(11):4992-4996. https://doi.org/10.1172/JCI122895.
Citation Information: J Clin Invest. 2018;128(11):4992-4996. https://doi.org/10.1172/JCI122895.
Abstract
Hemagglutination inhibition (HI) titers are a major correlate of protection for influenza-related illness. The influenza virus hemagglutinin possesses antigenic sites that are the targets of HI active antibodies. Here, a panel of mutant viruses each lacking a classically defined antigenic site was created to compare the species-specific immunodominance of the antigenic sites in a clinically relevant hemagglutinin. HI active antibodies of antisera from influenza virus–infected mice targeted sites Sb and Ca2. HI active antibodies of guinea pigs were not directed against any specific antigenic site, although trends were observed toward Sb, Ca2, and Sa. HI titers of antisera from infected ferrets were significantly affected by site Sa. HI active antibodies of adult humans followed yet another immunodominance pattern, in which sites Sb and Sa were immunodominant. When comparing the HI profiles among different species by antigenic cartography, animals and humans grouped separately. This study provides characterizations of the antibody-mediated immune responses against the head domain of a recent H1 hemagglutinin in animals and humans.
Authors
Sean T. H. Liu, Mohammad Amin Behzadi, Weina Sun, Alec W. Freyn, Wen-Chun Liu, Felix Broecker, Randy A. Albrecht, Nicole M. Bouvier, Viviana Simon, Raffael Nachbagauer, Florian Krammer, Peter Palese
Total citations by year
Citation information
Citations to this article (51)
| Title and authors | Publication | Year |
|---|---|---|
|
Influenza A Virus H7 nanobody recognizes a conserved immunodominant epitope on hemagglutinin head and confers heterosubtypic protection
Chen ZS, Huang HC, Wang X, Schön K, Jia Y, Lebens M, Besavilla DF, Murti JR, Ji Y, Sarshad AA, Deng G, Zhu Q, Angeletti D |
Nature Communications | 2025 |
|
Remapping the spatial distribution of neutralizing sites and their immunodominance on the capsid of different topotypes of FMDV serotype O by site-directed competitive ELISA for detection of neutralizing antibodies
Zhao Q, Li F, Huang S, Xing X, Sun Y, Li P, Bao H, Fu Y, Sun P, Bai X, Yuan H, Ma X, Zhao Z, Zhang J, Wang J, Wang T, Li D, Zhang Q, Qian P, Cao Y, Li K, Li X, Lu Z |
Microbiology Spectrum | 2025 |
|
Assessment of the antigenic evolution of a clade 6B.1 human H1N1pdm influenza virus revealed differences between ferret and human convalescent sera.
Fan S, Kong H, Babujee L, Presler R Jr, Jester P, Burke D, Pattinson D, Barr I, Smith D, Neumann G, Kawaoka Y |
EBioMedicine | 2024 |
|
Polymeric nanoparticle-based mRNA vaccine is protective against influenza virus infection in ferrets
Hardenberg G, Brouwer C, van Gemerden R, Jones NJ, Marriott AC, Rip J |
2024 | |
|
Within-host influenza viral diversity in the pediatric population as a function of age, vaccine, and health status
Sobel Leonard A, Mendoza L, McFarland AG, Marques AD, Everett JK, Moncla L, Bushman FD, Odom John AR, Hensley SE |
Virus Evolution | 2024 |
|
Preparation and characterization of mouse-derived monoclonal antibodies against the hemagglutinin of the H1N1 influenza virus
Lin X, Yang F, Yan S, Wu H, Wang P, Zhao Y, Shi D, Yao H, Wu H, Li L |
Virus Research | 2024 |
|
The immunodominance of antigenic site Sb on the H1 influenza virus hemagglutinin increases with high immunoglobulin titers of the cohorts and with young age, but not sex
Martínez JL, Lemus N, Lai TY, Mishra M, González-Domínguez I, Puente-Massaguer E, Loganathan M, Francis B, Samanovic MI, Krammer F, Mulligan MJ, Simon V, Palese P, Sun W |
Vaccine | 2024 |
|
Longitudinal assessment of human antibody binding to hemagglutinin elicited by split-inactivated influenza vaccination over six consecutive seasons
Carlock MA, Allen JD, Hanley HB, Ross TM |
PloS one | 2024 |
|
Immunity and Protective Efficacy of a Plant-Based Tobacco Mosaic Virus-like Nanoparticle Vaccine against Influenza a Virus in Mice.
Madapong A, Petro-Turnquist EM, Webby RJ, McCormick AA, Weaver EA |
Vaccines | 2024 |
|
An epidemiologic surveillance study based on wastewater and respiratory specimens reveals influenza a virus prevalence and mutations in Taiyuan, China during 2023-2024.
Zhao L, Xu J, Guo J, Zhang P, Guo X, Zuo Z, Gao L, Jia Z, Xue P, Wang J |
BMC infectious diseases | 2024 |
|
Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach
González-Domínguez I, Puente-Massaguer E, Abdeljawad A, Lai TY, Liu Y, Loganathan M, Francis B, Lemus N, Dolange V, Boza M, Slamanig S, Martínez-Guevara JL, Krammer F, Palese P, Sun W |
NPJ Vaccines | 2024 |
|
Seasonal influenza vaccines: Variability of immune responses to B lineage viruses.
Miller MS, Montomoli E, Leshem E, Schotsaert M, Weinke T, Vicic N, Rudin D |
Human vaccines & immunotherapeutics | 2024 |
|
Differential antigenic imprinting effects between influenza H1N1 hemagglutinin and neuraminidase in a mouse model
Lv H, Teo QW, Lee CC, Liang W, Choi D, Mao KJ, Ardagh MR, Gopal AB, Mehta A, Szlembarski M, Bruzzone R, Wilson IA, Wu NC, Mok CK |
Journal of Virology | 2024 |
|
Characterization of Influenza A(H1N1)pdm09 Viruses Isolated in the 2018-2019 and 2019-2020 Influenza Seasons in Japan.
Soga T, Duong C, Pattinson D, Sakai-Tagawa Y, Tokita A, Izumida N, Nishino T, Hagiwara H, Wada N, Miyamoto Y, Kuroki H, Hayashi Y, Seki M, Kasuya N, Koga M, Adachi E, Iwatsuki-Horimoto K, Yotsuyanagi H, Yamayoshi S, Kawaoka Y |
Viruses | 2023 |
|
2019-2020 H1N1 clade A5a.1 viruses have better in vitro fitness compared with the co-circulating A5a.2 clade.
Swanson NJ, Marinho P, Dziedzic A, Jedlicka A, Liu H, Fenstermacher K, Rothman R, Pekosz A |
Scientific Reports | 2023 |
|
Genetic characterization and whole-genome sequencing-based genetic analysis of influenza virus in Jining City during 2021-2022.
Li L, Liu T, Wang Q, Ding Y, Jiang Y, Wu Z, Wang X, Dou H, Jia Y, Jiao B |
Frontiers in microbiology | 2023 |
|
Use of Biolayer Interferometry to Identify Dominant Binding Epitopes of Influenza Hemagglutinin Protein of A(H1N1)pdm09 in the Antibody Response to 2010-2011 Influenza Seasonal Vaccine.
Guo Z, Lu X, Carney PJ, Chang J, Tzeng WP, York IA, Levine MZ, Stevens J |
Human vaccines | 2023 |
|
Development of PREDAC-H1pdm to model the antigenic evolution of influenza A/(H1N1) pdm09 viruses
Liu M, Liu J, Song W, Peng Y, Ding X, Deng L, Jiang T |
Virologica Sinica | 2023 |
|
Designed nanoparticles elicit cross-reactive antibody responses to conserved influenza virus hemagglutinin stem epitopes
McCraw DM, Myers ML, Gulati NM, Prabhakaran M, Brand J, Andrews S, Gallagher JR, Maldonado-Puga S, Kim AJ, Torian U, Syeda H, Boyoglu-Barnum S, Kanekiyo M, McDermott AB, Harris AK |
PLoS pathogens | 2023 |
|
Sequential vaccinations with divergent H1N1 influenza virus strains induce multi-H1 clade neutralizing antibodies in swine
Van Reeth K, Parys A, Gracia JC, Trus I, Chiers K, Meade P, Liu S, Palese P, Krammer F, Vandoorn E |
Nature Communications | 2023 |
|
2019–20 H1N1 clade A5a.1 viruses have better in vitro replication compared with the co-circulating A5a.2 clade
Swanson NJ, Marinho P, Dziedzic A, Jedlicka A, Liu H, Fenstermacher K, Rothman R, Pekosz A |
2023 | |
|
Targeting neuraminidase: the next frontier for broadly protective influenza vaccines
Wu NC, Ellebedy AH |
Trends in Immunology | 2023 |
|
Fc-Mediated Functions of Porcine IgG Subclasses
Paudyal B, Mwangi W, Rijal P, Schwartz JC, Noble A, Shaw A, Sealy JE, Bonnet-Di Placido M, Graham SP, Townsend A, Hammond JA, Tchilian E |
Frontiers in immunology | 2022 |
|
Greater Breadth of Vaccine-Induced Immunity in Females than Males Is Mediated by Increased Antibody Diversity in Germinal Center B Cells
Ursin RL, Dhakal S, Liu H, Jayaraman S, Park HS, Powell HR, Sherer ML, Littlefield KE, Fink AL, Ma Z, Mueller AL, Chen AP, Seddu K, Woldetsadik YA, Gearhart PJ, Larman HB, Maul RW, Pekosz A, Klein SL |
mBio | 2022 |
|
Identification and analysis of B cell epitopes of hemagglutinin of H1N1 influenza virus
Feng Q, Huang XY, Feng YM, Sun LJ, Sun JY, Li Y, Xie X, Hu J, Guo CY |
Archives of Microbiology | 2022 |
|
Immunodominance hierarchy after seasonal influenza vaccination.
Sánchez-de Prada L, Sanz-Muñoz I, de Lejarazu RO, Eiros JM, García-Sastre A, Aydillo T |
Emerging Microbes & Infections | 2022 |
|
Redirecting host preexisting influenza A virus immunity for cancer immunotherapy
BK Chaganty, S Qiu, Y Lu, G Lopez-Berestein, B Ozpolat, Z Fan |
Cancer Immunology, Immunotherapy | 2021 |
|
B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat
JJ Guthmiller, HA Utset, PC Wilson |
Viruses | 2021 |
|
First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes
JJ Guthmiller, J Han, L Li, AW Freyn, ST Liu, O Stovicek, CT Stamper, HL Dugan, ME Tepora, HA Utset, DJ Bitar, NJ Hamel, S Changrob, NY Zheng, M Huang, F Krammer, R Nachbagauer, P Palese, AB Ward, PC Wilson |
Science Translational Medicine | 2021 |
|
A Comprehensive Molecular and Epidemiological Characterization of Influenza Viruses Circulating 2016–2020 in North Macedonia
M Kuzmanovska, G Boshevska, E Janchevska, T Buzharova, M Simova, A Peshnacka, G Nikolovska, D Kochinski, R Ilioska, K Stavridis, V Mikikj, G Kuzmanovska, S Memeti, I Gjorgoski |
Frontiers in microbiology | 2021 |
|
Cluster of Oseltamivir-Resistant and Hemagglutinin Antigenically Drifted Influenza A(H1N1)pdm09 Viruses, Texas, USA, January 2020
T Mohan, H Nguyen, K Kniss, V Mishin, A Merced-Morales, J Laplante, K George, P Blevins, A Chesnokov, J Cruz, R Kondor, D Wentworth, L Gubareva |
Emerging infectious diseases | 2021 |
|
Influenza Virus and SARS-CoV-2 Vaccines
A Sandor, M Sturdivant, J Ting |
Journal of immunology (Baltimore, Md. : 1950) | 2021 |
|
Impaired Vaccine-Induced Antibody Response Against Clade 6B H1N1 Viruses in Individuals Before Viral Emergence
KY Huang, YC Huang, CH Chiu, KC Tsao, TY Lin |
Open Forum Infectious Diseases | 2020 |
|
Sequencing B cell receptors from ferrets (Mustela putorius furo)
J Wong, CM Tai, AC Hurt, HX Tan, SJ Kent, AK Wheatley, SM Tompkins |
PloS one | 2020 |
|
Subdominance in Antibody Responses: Implications for Vaccine Development
G Lindahl |
Microbiology and molecular biology reviews : MMBR | 2020 |
|
Flu Universal Vaccines: New Tricks on an Old Virus
R Du, Q Cui, L Rong |
Virologica Sinica | 2020 |
|
Host immune response–inspired development of the influenza vaccine
A Choi, A García-Sastre, M Schotsaert |
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology | 2020 |
|
H1 Hemagglutinin Priming Provides Long-Lasting Heterosubtypic Immunity against H5N1 Challenge in the Mouse Model
J Carreño, S Strohmeier, E Roubidoux, R Hai, P Palese, F Krammer, D Griffin |
mBio | 2020 |
|
Real-Time Investigation of a Large Nosocomial Influenza A Outbreak Informed by Genomic Epidemiology
W Javaid, J Ehni, A Gonzalez-Reiche, J Carreño, E Hirsch, J Tan, Z Khan, D Kriti, T Ly, B Kranitzky, B Barnett, F Cera, L Prespa, M Moss, R Albrecht, A Mustafa, I Herbison, M Hernandez, T Pak, H Alshammary, R Sebra, M Smith, F Krammer, M Gitman, E Sordillo, V Simon, H van Bakel |
Clinical Infectious Diseases | 2020 |
|
Implications of localized charge for human influenza A H1N1 hemagglutinin evolution: Insights from deep mutational scans
C Saad-Roy, N Arinaminpathy, N Wingreen, S Levin, J Akey, B Grenfell, R Antia |
PLoS computational biology | 2020 |
|
Antigenic characterization of novel H1 influenza A viruses in swine
R Tapia, M Torremorell, M Culhane, R Medina, V Neira |
Scientific Reports | 2020 |
|
Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020
D Skowronski, M Zou, S Sabaiduc, M Murti, R Olsha, J Dickinson, J Gubbay, M Croxen, H Charest, A Jassem, M Krajden, N Bastien, Y Li, G Serres |
Euro surveillance : bulletin europeen sur les maladies transmissibles = European communicable disease bulletin | 2020 |
|
Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin
JM Lee, R Eguia, SJ Zost, S Choudhary, PC Wilson, T Bedford, T Stevens-Ayers, M Boeckh, AC Hurt, SS Lakdawala, SE Hensley, JD Bloom |
eLife | 2019 |
|
The human antibody response to influenza A virus infection and vaccination
F Krammer |
Nature Reviews Immunology | 2019 |
|
Universal Influenza Virus Vaccines That Target the Conserved Hemagglutinin Stalk and Conserved Sites in the Head Domain
F Krammer, P Palese |
The Journal of Infectious Diseases | 2019 |
|
Protective Antibodies Against Influenza Proteins
HO Padilla-Quirarte, DV Lopez-Guerrero, L Gutierrez-Xicotencatl, F Esquivel-Guadarrama |
Frontiers in immunology | 2019 |
|
Improving immunological insights into the ferret model of human viral infectious disease
J Wong, D Layton, AK Wheatley, SJ Kent |
Influenza and Other Respiratory Viruses | 2019 |
|
Antiviral Activities of Hibiscus sabdariffa L. Tea Extract Against Human Influenza A Virus Rely Largely on Acidic pH but Partially on a Low-pH-Independent Mechanism
Y Takeda, Y Okuyama, H Nakano, Y Yaoita, K Machida, H Ogawa, K Imai |
Food and Environmental Virology | 2019 |
|
An Inactivated Influenza Virus Vaccine Approach to Targeting the Conserved Hemagglutinin Stalk and M2e Domains
W Sun, A Zheng, R Miller, F Krammer, P Palese |
Human vaccines | 2019 |
|
The post-2009 influenza pandemic era: time to revisit antibody immunodominance
Kristien Van Reeth |
Journal of Clinical Investigation | 2018 |
|
Antibody Responses toward the Major Antigenic Sites of Influenza B Virus Hemagglutinin in Mice, Ferrets, and Humans
W Sun, DS Kang, A Zheng, ST Liu, F Broecker, V Simon, F Krammer, P Palese, TS Dermody |
Journal of virology | 2018 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)